This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eppendorf Ag. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Satoshi Ezaki: Innovator in Nucleotide Sequencing
Introduction
Satoshi Ezaki is a prominent inventor based in Ibaragi, Japan. He has made significant contributions to the field of biotechnology, particularly in the area of nucleotide sequencing. His innovative work has implications for various applications in genetic research and diagnostics.
Latest Patents
Ezaki holds a patent for a "Method for determining nucleotide sequences." This invention relates to an improved method for determining nucleotide sequences or nucleotide sequences on biochips and micro-assays. Specifically, it utilizes p53 mediated hybridization, focusing on the use of p53 polypeptides to determine changes in nucleotide sequences. This advancement enhances the accuracy and efficiency of genetic analysis.
Career Highlights
Satoshi Ezaki is currently employed at Eppendorf AG, a company known for its innovative solutions in the life sciences sector. His work at Eppendorf AG allows him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ezaki has worked alongside notable colleagues, including Stefanie Häfele and Till Bachmann. Their collaborative efforts have furthered advancements in biotechnology and have led to significant developments in genetic research.
Conclusion
Satoshi Ezaki's contributions to nucleotide sequencing exemplify the impact of innovative thinking in biotechnology. His work continues to influence the field and pave the way for future advancements in genetic analysis.